Showing results (21-30 of 2,411) with videos related to

Sort By:
Pageof 242
The Journal of Biological Chemistry|July 1, 2008
Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-MycDakang Xu, Julie Dwyer, He Li, et al.
The Journal of Biological Chemistry|June 21, 2006
Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT geneHe Li, Dakang Xu, Jinhua Li, et al.
Immunology Letters|February 26, 2003
Characterization of monoclonal antibodies specific to the transcription factor ETS-2 proteinElaine Sanij, Bernadette Scott, Trevor Wilson, et al.
Genesis (New York, N.Y. : 2000)|August 31, 2002
A human CD2 minigene directs CRE-mediated recombination in T cells in vivoTrevor J Wilson, Helen E Cowdery, Dakang Xu, et al.
Molecular Cancer Therapeutics|May 20, 2016
Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor PracinostatDhanya Sooraj, Dakang Xu, Jason E Cain, et al.
Frontiers in Immunology|August 28, 2020
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor MicroenvironmentKaiyue Wu, Kangjia Lin, Xiaoyan Li, et al.
Biochimica Et Biophysica Acta|December 21, 2004
Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DSDebra A O'Leary, Melanie A Pritchard, Dakang Xu, et al.
Clinical and Experimental Pharmacology & Physiology|August 18, 2017
(-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver diseaseLe Ying, Feng Yan, Yueling Zhao, et al.
Oncogene|October 20, 2021
Complete loss of miR-200 family induces EMT associated cellular senescence in gastric cancerLiang Yu, Can Cao, Xu Li, et al.
Clinical and Experimental Pharmacology & Physiology|March 6, 2015
The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancerMuyang Ding, Hang Zhang, Zhen Li, et al.
Pageof 242